ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
2,456 announcements with these filters
Q2 FY27: total business ₹1,30,237 Cr (+27.25% YoY), record net profit ₹451 Cr (+42.09%), ROE 16.92%, GNPA 0.61%, NNPA 0.14%.
Q2 FY27 consolidated revenue ₹1,054 cr (+26%), EBITDA ₹337 cr (+37%), PAT ₹203 cr (+52%). Asset-right expansion continues.
Syrma delivered an exceptionally strong Q1 with 67% revenue growth and 112% PAT growth, driven by export buoyancy and ODM traction.
Q2FY27 consolidated revenue Rs87.4 Cr (+52% YoY), EBITDA Rs24.4 Cr (28% margin), PAT Rs11.3 Cr (+149%); pitch centres on oncology integration.
Q2 FY27 consolidated revenue ₹892 Cr (+12.6%), PAT ₹187 Cr (+39.2%), EBITDA margin 34.7%. H1 PAT ₹330 Cr (+27.3%). Zorvia out-licensing supports DBF gross margin.
Q2 FY27 RE net total income ₹268 Cr (+755% YoY), continuing EBITDA ₹195 Cr, collections ₹752 Cr (+47%). Net debt cut to ₹284 Cr; shift toward cash monetisation.
Q2 FY27 standalone revenue ₹3,361 Cr (+40% YoY), PAT ₹279 Cr (+44%), EBITDA margin 12.8% (+41bps). H1 revenue ₹6,079 Cr (+21.5%), PAT ₹487 Cr. Debt-free, cash ₹685 Cr; growth price-led.
Triveni delivers resilient growth despite supply chain delays, shifting toward high-margin defense and aftermarket segments. Management remains aggressive on international expansion while navigating a lumpy defense procurement cycle.
Q2FY27 consolidated revenue ₹70.0Bn (+34% YoY), EBITDA ₹5.8Bn (+29%), PAT ₹3.8Bn (+27%), volume 963k ton (+13%). Net cash ₹16.3Bn; capacity targeted at 8 Mn ton by FY28.
TruAlt reported massive 606% YoY revenue growth, turning profitable despite raw material price surges. Management is pivoting from ethanol to high-margin CBG to insulate from feedstock volatility.
Adani Power delivered record Q2 results driven by robust demand and high plant availability. One-time revenue from Gujarat PPA and operational efficiency significantly boosted PAT.
Apollo reported record-breaking performance driven by defense indigenization, yet consolidated margins are temporarily dampened by the transition of loss-making subsidiary Ideal Explosives.
BPCL managed a resilient Q2 despite crude volatility and high freight, benefiting from strong distillate yields and Russian discounts, though marketing margins faced significant under-recovery pressure.
Q2FY27 consolidated revenue ₹264 Cr (+6% YoY, -9% QoQ), EBITDA ₹16 Cr at 6.2% margin, PAT ₹3 Cr versus prior-year loss of ₹9 Cr. Margins compressed on input costs.
SSWL delivered its strongest-ever quarter driven by alloy wheel premiumization and a sharp CV recovery.
Standalone H1 FY27: PAT ₹16.03 Cr (+147% YoY), total income ₹49.87 Cr, AUM ₹610.24 Cr. Growth driven by secured MSME and digital lending, funded by ₹424 Cr of NCDs and term loans.
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
SBFC delivered consistent performance, achieving its 36th consecutive quarter of growth with a 15% ROE despite shifting focus away from micro-MSME segments.
Kajaria delivered solid volume growth and margin expansion despite subdued exports from Morbi. Management remains optimistic about double-digit volume growth driven by domestic demand and capacity expansions.
Unicommerce delivered 15% revenue growth while aggressively investing in AI and new product modules like UniReco.
Q2 FY27 consolidated revenue ₹53.6 Cr (+88.2% YoY), EBITDA ₹15.8 Cr (29.5% margin), PAT ₹11.2 Cr (+145.1%), driven by SGB Limited premiumisation and 5.76 lakh MTPA scale.
Q2 FY27 continuing revenue ₹17,528 Cr (+28.5% YoY), continuing EBITDA ₹6,321 Cr (+18.5%), PAT ₹7,019 Cr; reported PAT inflated by one-time income.
IDFC First Bank reports its second consecutive quarter of PAT over ₹1,000 Cr, heavily impacted by massive FCNR mobilization which technicality suppressed NIMs while providing long-term structural liquidity.
H1 FY27 revenue ₹7,999.85 Cr (+16.06% YoY); PAT ₹55.65 Cr vs ₹123.88 Cr. Q2 PAT ₹123.74 Cr vs loss ₹52.99 Cr. FY27 capex target ₹1,000 Cr.
Q2FY27 revenue INR 1,556 Cr (+35% YoY), PAT INR 117 Cr (+50%), EBITDA margin flat at 14.7%. Strategy anchored on a 20% revenue CAGR North Star through FY31e.
Record H1FY27 profitability: consolidated Q2 revenue INR 157 Cr (+31% YoY), Q2 PAT INR 17 Cr, H1 PAT INR 38 Cr. Integrated recycling capex and PCMB scale-up underway.
H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.
Q2 FY27 revenue ₹12,960 lakh (+231.8% YoY), Op EBITDA margin 9.6%, PAT ₹770 lakh (+450.8%). Strategy: DLM mix shift, telecom and AI expansion.
Q2 FY27 consolidated revenue ₹1,468 Cr (+24% YoY), EBITDA ₹286.5 Cr (19.5% margin), PAT ₹189.5 Cr (+43%). Capacity expansions on track.
AU SFB shows strong growth momentum despite a tight liquidity environment. Management is focused on granular deposit mobilization and leveraging technology to improve operating efficiency.